RecallDepth
Class III Terminated

Dacarbazine, Injection, USP, 200mg, vials packaged in individual cartons, Rx only, Manufactured by Hospira Australia 1 Lexia Place, Mulgrave, Victoria Australia 3170. NDC 61703-327-22.

Company
Hospira Inc.
Recall Initiated
November 25, 2014
Posted
December 31, 2014
Recall Number
D-0313-2015
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
3,306 vials
Firm Location
Lake Forest, IL, United States

Reason for Recall

Discoloration: Reconstituted solution may appear pink instead of colorless to pale yellow when stored per the labeled conditions.

Distribution

Nationwide

Lot / Code Info

Lot #: B032223AA; Exp: July 2016

More recalls by Hospira Inc.

View all recalls by this company →

Other recent Class III Drug recalls